CFO
GH icon

Callan Family Office’s Guardant Health GH Stock Holding History

Callan Family Office’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$912K Buy
6,080
+2,480
+69% +$270K 0.02% 622
2026
Q1 		$333K Buy
+3,600
New +$361K 0.01% 896

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Callan Family Office's GH Position: Q2 2026 in Review

Callan Family Office increased its Guardant Health (GH) stake by 69% in Q2 2026, buying an estimated $270K and bringing the position to 6,080 shares worth $912K. The position accounts for 0.02% of the portfolio, ranked #622.

Callan Family Office first reported a position in GH in Q1 2026 and has held it in 2 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Callan Family Office held 6,080 shares of Guardant Health worth $912K as of Q2 2026.
  • Callan Family Office bought 2,480 Guardant Health shares in Q2 2026, an estimated $270K.
  • Guardant Health made up 0.02% of Callan Family Office's portfolio in Q2 2026, its #622 holding.
  • Callan Family Office first reported a position in Guardant Health in Q1 2026 and has held it in 2 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.